文献速递冠心病

衰弱与非ST段抬高型急性冠脉综合征侵入性治疗后的生活质量

Frailty and quality of life after invasive management for non-ST elevation acute coronary syndrome.
PubMed 文献 · Heart · 2021-05-14

本研究为纵向队列研究,纳入217例≥65岁非ST段抬高型急性冠脉综合征(NSTEACS)患者,采用Fried衰弱指数评估衰弱状态,SF-36评估健康相关生活质量(HRQoL)。结果显示衰弱患者基线HRQoL较差,但侵入性治疗后1年衰弱和衰弱前期患者在多领域HRQoL改善更明显。

要点

  • 衰弱患者基线时所有SF-36躯体领域评分均低于非衰弱患者(p≤0.05)。
  • 侵入性治疗后1年,衰弱和衰弱前期患者 collectively 在11个领域改善,而健壮患者仅2个领域改善。
  • 衰弱患者角色躯体改善+10.4(95%CI 6.78-14.1),衰弱前期+6.53(95%CI 3.85-9.20)。

核心结论

  • 衰弱老年NSTEACS患者HRQoL较差,侵入性治疗后1年有适度改善,衰弱和衰弱前期患者获益比例更大。

研究设计与样本

  • 纵向队列研究,纳入217例≥65岁(平均80.9±4.0岁,60.8%男性)NSTEACS患者,来自两个三级心脏中心,2012年11月至2015年12月。
  • 衰弱采用Fried衰弱指数评估:0分为健壮,1-2分为衰弱前期,≥3分为衰弱;SF-36在基线和1年时评估。

主要发现

  • 186例(85.7%)接受了侵入性血运重建。
  • 基线时52例(23.9%)衰弱,121例(55.8%)衰弱前期,多数SF-36领域低于常模人群均值。
  • 衰弱患者所有SF-36躯体领域平均评分均低于非衰弱患者(p≤0.05)。
  • 健壮患者2个领域随时间改善:角色躯体+5.80(95%CI 1.31-10.3),角色情绪+6.46(95%CI 1.02-11.9)。
  • 衰弱和衰弱前期患者 collectively 在11个领域改善,角色躯体:衰弱前期+6.53(95%CI 3.85-9.20),衰弱+10.4(95%CI 6.78-14.1)。

临床怎么用

  • 对老年NSTEACS患者应进行衰弱评估,以识别HRQoL较差的高危人群。
  • 衰弱和衰弱前期患者接受侵入性治疗后HRQoL改善更明显,不应仅因衰弱而排除侵入性管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Older patients presenting with non-ST elevation acute coronary syndrome (NSTEACS) require holistic assessment. We carried out a longitudinal cohort study to investigate health-related quality of life (HRQoL) of older, frail adults with NSTEACS undergoing coronary angiography. METHODS: 217 consecutive patients aged ≥65 years (mean age 80.9±4.0 years, 60.8% male) with NSTEACS referred for coronary angiography were recruited from two tertiary cardiac centres between November 2012 and December 2015. Frailty was assessed with the Fried Frailty Index; a score of 0 was characterised as robust, 1-2 prefrail and ≥3 frail. The Short Form Survey 36 (SF-36), an HRQoL tool consisting of eight domains spanning physical and mental health, was performed at baseline and 1 year. RESULTS: 186 patients (85.7%) had invasive revascularisation. At baseline, 52 (23.9%) patients were frail and 121 (55.8%) were prefrail, with most SF-36 domains falling below the norm-population mean. Patients with frailty had lower mean scores in all physical SF-36 domains (p≤0.05) compared with those without frailty. Robust patients had temporal improvement in two domains (role physical +5.80 (95% CI 1.31 to 10.3) and role emotional +6.46 (95% CI 1.02 to 11.9)) versus patients with frailty and prefrailty, who had a collective improvement in a greater number of physical and psychological domains at 1 year (2 domains vs 11 domains), notably role physical (prefrail +6.53 (95% CI 3.85 to 9.20) and frail +10.4 (95% CI 6.7814.1)). CONCLUSIONS: Frail older adults with NSTEACS have poor HRQoL. One year following invasive management, there are modest improvements in HRQoL, most marked in frail and prefrail patients, who received a proportionally larger benefit than robust patients. TRIAL REGISTRATION NUMBER: NCT01933581.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Beska B, Coakley D, MacGowan G, et al. Frailty and quality of life after invasive management for non-ST elevation acute coronary syndrome. Heart. 2021. PMID: 33990413. doi:10.1136/heartjnl-2021-319064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。